Navigation Links
United States Patent Office Grants CryoCor's Request for Patent Interference
Date:2/13/2008

CryoCor Named Senior Party in Interference

SAN DIEGO, Feb. 13 /PRNewswire-FirstCall/ -- CryoCor, Inc. (Nasdaq: CRYO), a medical device company focused on the treatment of cardiac arrhythmias, announced today that the United States Patent and Trademark Office (USPTO) has declared a patent interference between a patent application exclusively licensed by CryoCor and two patents held by CryoCath Technologies Inc. A patent interference is an administrative proceeding within the USPTO to establish which party was the first to invent certain subject matter and, therefore, should have patent rights to the technology. The patent interference is related to certain pre-cooling technologies that CryoCor considers important to CryoCath's cryoablation system.

The USPTO designated CryoCor to be the senior party in the interference as its patent application was found to predate CryoCath's original patent applications. In an interference proceeding, the burden of proof is on the junior party (in this case, CryoCath) to establish an earlier date of invention. The interference dispute will be determined by the Board of Patent Appeals and Interferences and presided over by an Administrative Patent Judge. The proceedings are scheduled to begin in March 2008 and the Company expects a final judgment to be made in 2009. CryoCor reported that a second interference, also in the field of pre-cooling, is anticipated to be declared by the USPTO in the first half of 2008.

Ed Brennan, Ph.D., President and Chief Executive Officer of CryoCor, said, "We are very pleased with USPTO's decision to grant CryoCor's request to declare this interference, and we anticipate a second interference between CryoCor and CryoCath to be declared in the near future. We believe we have broad coverage in our patent portfolio covering pre-cooling, which we consider important for a cryoablation system. These patent interferences are an important part of our strategy to secure ou
'/>"/>

SOURCE CryoCor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. United Therapeutics to Announce Fourth Quarter and Annual 2007 Financial Results Before Market Open on Tuesday, February 19, 2008
2. Energy Conversion Devices and United Solar Ovonic Enter Into New $55 Million Secured Credit Facility Agreements
3. Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor
4. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
5. Neptune Technologies receives GRAS notification in the United States
6. Essilor: New Acquisitions in the United States and Brazil
7. Neptune Technologies & Bioressources Inc. Secures Access to Nationwide Consumer Mass Market in the United States
8. Medical Services Begins Working With United States Companies for Distribution of Its Products
9. United Therapeutics Reports Third Quarter 2007 Financial Results
10. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
11. ISTO Technologies Granted Key Patent for Cartilage Cell Expansion by the United States Patent Office

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... , , REYKJAVIK, Iceland,...tics, Inc. (Nasdaq: DCGN ) today announced that it...that trading in the company,s common stock will be...SE will be filed with the,Securities and Exchange ...k,from listing on Nasdaq, unless the company files...
(Date:11/24/2009)... , Health care employmen...emains the only one to show consistent growth duri...lty hospitals remain in trouble, and health system...cal personnel, instead of just administrators. , ...-- Health care employment continued growing in Oct...
(Date:11/24/2009)... , , SHANGHAI, Nov. 24 /PRNewswire...S Patent & Trademark Office (PTO) has allowed ...delivery or NOD technology. , NOD technol...peptides or,proteins into bio-adhesive nano-partic...inistered as injections. NOD technology is a platf...
(Date:11/24/2009)... , , SHANGHAI, Nov. 24 /PRNewswi... State Food & Drug Administration (SFDA) has a...IND) for its oral insulin project,(Nodlin), an inn...s IND,approval allows Biolaxy to initiate its firs... disorder characteristic of high blood glucose and...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...attendees from 47 countries convene in Seattle for...ce, SEATTLE, Aug. 20 More than 900 global resear...k for the AIDS Vaccine 2007,Conference at the Sher...ine,2000 Conference in Paris, this event has emerg...ific information relating to the difficult task of...
...ug. 14 Transgenomic, Inc. (the,"Company") (OTC Bu...lts for,the quarter ended June 30, 2007. The Compa... that follow. Second Quarter 2007 The Company re...hare,for the second quarter of 2007 as compared to... the second quarter of 2006. The 2007 net profit w...
...ug. 14 Response Genetics, Inc.,(Nasdaq: RGDX ), ...arter,ended June 30, 2007. "The second quarter of...nning with our successful initial public offering ...EO of Response Genetics. "We are very,pleased by t...ced. During,the quarter these developments include...
Other Biology Technology:Global Experts Explore Entire Spectrum of Aids Vaccine Development 2Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Response Genetics Reports Second Quarter 2007 Financial Results 2Response Genetics Reports Second Quarter 2007 Financial Results 3Response Genetics Reports Second Quarter 2007 Financial Results 4Response Genetics Reports Second Quarter 2007 Financial Results 5Response Genetics Reports Second Quarter 2007 Financial Results 6Response Genetics Reports Second Quarter 2007 Financial Results 7Response Genetics Reports Second Quarter 2007 Financial Results 8
(Date:11/24/2009)...NEW YORK (November 24, 2009) -- The Wildlife Conse...ealing that the last remaining population of Siber...o the rising tide of poaching and habitat loss. ,... Russian officials of what needs to be done to pro...cat. , The report was released by t...
(Date:11/24/2009)...s fish food is a matter of debate. A high-profile ...st 50 percent of their carbon from trees and leave...estrial and aquatic ecosystems. , But new resear... not likely to be true. Algae provide a much riche...to research published this week in the Proceeding...
(Date:11/24/2009)... available in Spanish . , The presence of i...inflammatory substances in the blood, hinders the ... research project of the University of Navarra con... the School of Pharmacy. , The project, entitled...n to the control of body weight and inflammation,"...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3It can be predicted the reaction obese patients will have to a diet 2VBI awarded 2427 million from NIH to support infectious disease research 10266 1VBI awarded 2427 million from NIH to support infectious disease research 10266 2VBI awarded 2427 million from NIH to support infectious disease research 10266 3VBI awarded 2427 million from NIH to support infectious disease research 10266 4Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 1Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 2Expert Panel of Pediatric Liver Specialists Publishes Recommendations for Monitoring and Referral of Children With Chronic Hepatitis B Infections 58887 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 1 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 2 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 3 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 4 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 5 2416 Million in Federal Stimulus Funding Establishes Seattle as a Hub of Comparative Effectiveness Research In Cancer 58883 6
...er development may provide protection against high...ording to researchers at Purdue University and the...scovered the new preventative drug and have tested...nes, the new vaccine could be produced quickly and...emic of dangerous disease-causing avian influenza ...
...or truck trailers by mounting sideskirts can lead ...o as much as 15%. Earlier promising predictions, b...by TU Delft, have been confirmed during road tests...rivate platform PART (Platform for Aerodynamic Roa...n immediately be put into production. , It is exp...
... , , Every two minutes in Germany, one person su... not survive the sudden lack of blood in the brain...Since the brain is a high-performance organ with a...gen is interrupted, it reacts with paralyses, impa...ng of the underlying processes in the brain, resea...
Other Biology News:New vaccine may give long-term defense against deadly bird flu and its variant forms 2New vaccine may give long-term defense against deadly bird flu and its variant forms 3New vaccine may give long-term defense against deadly bird flu and its variant forms 4Aerodynamic trailer cuts fuel and emissions by up to 15 percent 2Tracking stroke 2
L-Selenomethionine from Calbiochem
PAP PEN from Invitrogen
EL4 Cell Slide from ProSci, Inc
Jurkat Cell Slide from ProSci, Inc
Biology Products: